Objective: To evaluate the radiofrequency ablation for benign thyroid nodules and to analyze the factors influencing post-procedural nodule regrowth. Methods: A total of 187 patients(242 thyroid nodules) treated at the Department of Ultrasonography, Hospital of Integrated Traditional and Western Medicine Affiliated to Nanjing University of Chinese Medicine between January 2021 and December 2022 were enrolled. All patients underwent thyroid radiofrequency ablation. Patient baseline characteristics, nodule volume, and volume reduction rate(VRR) at various follow-up time points were collected. Univariate and multivariate Cox regression analyses were performed to identify factors influencing nodule regrowth after radiofrequency ablation. Results: The study included 187 patients, comprising 148 females(191 nodules) and 39 males(51 nodules). The VRR progressively increased at 1, 3, 6, and 12 months post-operation. VRR showed positive correlations with ablation time per unit volume(r=0.165, P=0.017), presence of calcification(r=0.165, P=0.017), RADS classification(r=0.169, P=0.014), nodule boundary clarity(r=0.169, P=0.014), and gender(r=0.140, P=0.044). Negative correlations were observed between VRR and intranodular blood flow(r=-0.221, P=0.001), perinodular blood flow(r=-0.227, P=0.001), and initial nodule volume(r=-0.200, P=0.005). Multivariate Cox analysis identified solid composition(HR=3.879, P=0.037), mixed echogenicity(HR=9.008, P=0.045), abundant perinodular blood flow(HR=3.840, P=0.020), and longer ablation time per unit volume(HR=1.001, P=0.022) as independent risk factors for nodule regrowth. Conclusion: Nodule regrowth is significantly associated with nodule composition, initial volume, and the distribution of intra- and perinodular blood flow. Solid composition, mixed echogenicity, abundant perinodular blood flow, and longer ablation time per unit volume are risk factors for regrowth. |
[1] COHEN R N,DAVIS A M.Management of adult patients with thyroid nodules and differentiated thyroid cancer[J].JAMA,2017,317(4):434-435.
[2] ALEXANDER E K,HURWITZ S,HEERING J P,et al.Natural history of benign solid and cystic thyroid nodules[J].Ann Intern Med,2003,138(4):315-318.
[3] BATRA H,YARMUS L.Indications and complications of rigid bronchoscopy[J].Expert Rev Respir Med,2018,12(6):509-520.
[4] LEE S,SKELTON T S,ZHENG F,et al.The biopsy-proven benign thyroid nodule:is long-term follow-up necessary?[J].J Am Coll Surg,2013,217(1):81-89.
[5] KIM Y S,RHIM H,TAE K,et al.Radiofrequency ablation of benign cold thyroid nodules:initial clinical experience[J].Thyroid,2006,16(4):361-367.
[6] 周辉生,李桂英,陈佑江.超声引导下经皮微波消融治疗微小甲状腺乳头状癌[J].现代医学,2020,48(3):373-378.
[7] 陆昌明,曾自三,白涛.影像技术在肿瘤介入治疗中的应用进展[J].现代医学,2023,51(4):560-565.
[8] DEANDREA M,TRIMBOLI P,GARINO F,et al.Long-term efficacy of a single session of RFA for benign thyroid nodules:a longitudinal 5-year observational study[J].J Clin Endocrinol Metab,2019,104(9):3751-3756.
[9] BERNARDI S,CAVALLARO M,COLOMBIN G,et al.Initial ablation ratio predicts volume reduction and retreatment after 5 years from radiofrequency ablation of benign thyroid nodules[J].Front Endocrinol,2020,11:582550.
[10] JIAO Z,LUO Y,SONG Q,et al.Roles of contrast-enhanced ultrasonography in identifying volume change of benign thyroid nodule and optical time of secondary radiofrequency ablation[J].BMC Med Imaging,2020,20(1):79.
[11] BAEK J H,LEE J H,VALCAVI R,et al.Thermal ablation for benign thyroid nodules:radiofrequency and laser[J].Korean J Radiol,2011,12(5):525-540.
[12] PARK H S,BAEK J H,PARK A W,et al.Thyroid radiofrequency ablation:updates on innovative devices and techniques[J].Korean J Radiol,2017,18(4):615-623.
[13] MAURI G,PACELLA C M,PAPINI E,et al.Image-guided thyroid ablation:proposal for standardization of terminology and reporting criteria[J].Thyroid,2019,29(5):611-618.
[14] PAPINI E,MONPEYSSEN H,FRASOLDATI A,et al.2020 European thyroid association clinical practice guideline for the use of image-guided ablation in benign thyroid nodules[J].Eur Thyroid J,2020,9(4):172-185.
[15] BERNARDI S,DOBRINJA C,FABRIS B,et al.Radiofrequency ablation compared to surgery for the treatment of benign thyroid nodules[J].Int J Endocrinol,2014,2014:934595.
[16] 谭海鹏,黄浙勇.巨噬细胞对凋亡细胞的清除及炎症调控作用[J].复旦学报(医学版),2020,47(6):911-916.
[17] WANG B,HAN Z Y,YU J,et al.Factors related to recurrence of the benign non-functioning thyroid nodules after percutaneous microwave ablation[J].Int J Hyperthermia,2017,33(4):459-464.
[18] HA E J,BAEK J H,KIM K W,et al.Comparative efficacy of radiofrequency and laser ablation for the treatment of benign thyroid nodules:systematic review including traditional pooling and Bayesian network meta-analysis[J].J Clin Endocrinol Metab,2015,100(5):1903-1911.
[19] 付倩倩,吴翠萍,王诗雨,等.超声引导下微波消融治疗甲状腺良性结节效果及其影响因素[J].中国介入影像与治疗学,2021,18(7):393-397.
[20] FU Q Q,KANG S,WU C P,et al.A study on the efficacy of microwave ablation for benign thyroid nodules and related influencing factors[J].Int J Hyperthermia,2021,38(1):1469-1475.
[21] ZHAO C K,XU H X,LU F,et al.Factors associated with initial incomplete ablation for benign thyroid nodules after radiofrequency ablation:first results of CEUS evaluation[J].Clin Hemorheol Microcirc,2017,65(4):393-405.
[22] DEANDREA M,GARINO F,ALBERTO M,et al.Radiofrequency ablation for benign thyroid nodules according to different ultrasound features:an Italian multicentre prospective study[J].Eur J Endocrinol,2019,180(1):79-87. |